Cargando…
A multicenter randomized controlled trial of surgery alone or surgery with atrial natriuretic peptide in lung cancer surgery: study protocol for a randomized controlled trial
BACKGROUND: Postoperative cancer recurrence is a major problem following curative surgery. In a previous retrospective study of lung cancer surgery, we reported that administration of atrial natriuretic peptide (ANP) during the perioperative period reduced postoperative recurrence. We demonstrated t...
Autores principales: | Nojiri, Takashi, Yamamoto, Haruko, Hamasaki, Toshimitsu, Onda, Kaori, Ohshima, Kikuko, Shintani, Yasushi, Okumura, Meinoshin, Kangawa, Kenji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5397773/ https://www.ncbi.nlm.nih.gov/pubmed/28427456 http://dx.doi.org/10.1186/s13063-017-1928-1 |
Ejemplares similares
-
The world's first clinical randomized trial of atrial natriuretic peptide for preventing cancer recurrence following lung cancer surgery
por: Nojiri, Takashi, et al.
Publicado: (2015) -
A novel physiological significance of natriuretic peptides in cancer metastasis
por: Kangawa, Kenji, et al.
Publicado: (2013) -
Landiolol, an ultra-short acting beta-1 blocker, for preventing postoperative lung cancer recurrence: study protocol for a phase III, multicenter randomized trial with two parallel groups of patients
por: Yamamoto, Haruko, et al.
Publicado: (2019) -
C-type natriuretic peptide ameliorates pulmonary fibrosis by acting on lung fibroblasts in mice
por: Kimura, Toru, et al.
Publicado: (2016) -
Erratum to: C-type natriuretic peptide ameliorates pulmonary fibrosis by acting on lung fibroblasts in mice
por: Kimura, Toru, et al.
Publicado: (2016)